- Home
- CIEN vs SNN Comparison
CIEN vs SNN Comparison
Compare CIEN & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIEN
- SNN
- Stock Information
- Founded
- CIEN 1992
- SNN 1856
- Country
- CIEN United States
- SNN United Kingdom
- Employees
- CIEN N/A
- SNN N/A
- Industry
- CIEN Telecommunications Equipment
- SNN Industrial Specialties
- Sector
- CIEN Utilities
- SNN Health Care
- Exchange
- CIEN Nasdaq
- SNN Nasdaq
- Market Cap
- CIEN 27.4B
- SNN 15.2B
- IPO Year
- CIEN 1997
- SNN 1999
- Fundamental
- Price
- CIEN $191.10
- SNN $32.78
- Analyst Decision
- CIEN Strong Buy
- SNN Hold
- Analyst Count
- CIEN 15
- SNN 4
- Target Price
- CIEN $141.29
- SNN $32.83
- AVG Volume (30 Days)
- CIEN 2.7M
- SNN 613.9K
- Earning Date
- CIEN 12-11-2025
- SNN 10-30-2025
- Dividend Yield
- CIEN N/A
- SNN 2.24%
- EPS Growth
- CIEN 3.32
- SNN 59.91
- EPS
- CIEN 0.98
- SNN 0.56
- Revenue
- CIEN $4,541,635,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- CIEN $19.58
- SNN $7.85
- Revenue Next Year
- CIEN $16.89
- SNN $5.43
- P/E Ratio
- CIEN $195.70
- SNN $28.37
- Revenue Growth
- CIEN 12.97
- SNN 5.35
- 52 Week Low
- CIEN $49.21
- SNN $23.69
- 52 Week High
- CIEN $214.17
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- CIEN 56.41
- SNN 32.54
- Support Level
- CIEN $200.75
- SNN $33.05
- Resistance Level
- CIEN $211.07
- SNN $33.66
- Average True Range (ATR)
- CIEN 9.80
- SNN 0.49
- MACD
- CIEN -1.36
- SNN -0.34
- Stochastic Oscillator
- CIEN 41.39
- SNN 17.80
About CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.